Evidence map›Paper›PMID 37139155›Full record

ArticleFrontiers in oncology2023

Deregulated expression of the 14q32 miRNA cluster in clear cell renal cancer cells.

Ravneet Chhabra, Jennifer Guergues, Jessica Wohlfahrt, Stephanie Rockfield, Pamela Espinoza Gonzalez, Shanon Rego, Margaret A Park, Anders E Berglund, Stanley M Stevens, Meera Nanjundan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ravneet ChhabraDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Jennifer GuerguesDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Jessica WohlfahrtDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Stephanie RockfieldDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Pamela Espinoza GonzalezDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Shanon RegoDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Margaret A ParkDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Anders E BerglundDepartment of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States.
Stanley M StevensDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
Meera NanjundanDepartment of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL, United States.
University of South Florida · USMoffitt Cancer Center · USSt. Jude Children's Research Hospital · US

Funding

The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer BiologyR03CA212696 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI NANJUNDAN, MEERA · 2017 to 2018
$150k
NCI NIH HHS R03 CA212696
6 · The paper itself

Abstract

Clear cell renal cell carcinomas (ccRCC) are characterized by arm-wide chromosomal alterations. Loss at 14q is associated with disease aggressiveness in ccRCC, which responds poorly to chemotherapeutics. The 14q locus contains one of the largest miRNA clusters in the human genome; however, little is known about the contribution of these miRNAs to ccRCC pathogenesis. In this regard, we investigated the expression pattern of selected miRNAs at the 14q32 locus in TCGA kidney tumors and in ccRCC cell lines. We demonstrated that the miRNA cluster is downregulated in ccRCC (and cell lines) as well as in papillary kidney tumors relative to normal kidney tissues (and primary renal proximal tubule epithelial (RPTEC) cells). We demonstrated that agents modulating expression of DNMT1 (e.g., 5-Aza-deoxycytidine) could modulate 14q32 miRNA expression in ccRCC cell lines. Lysophosphatidic acid (LPA, a lysophospholipid mediator elevated in ccRCC) not only increased labile iron content but also modulated expression of a 14q32 miRNA. Through an overexpression approach targeting a subset of 14q32 miRNAs (specifically at subcluster A: miR-431-5p, miR-432-5p, miR-127-3p, and miR-433-3p) in 769-P cells, we uncovered changes in cellular viability and claudin-1, a tight junction marker. A global proteomic approach was implemented using these miRNA overexpressing cell lines which uncovered ATXN2 as a highly downregulated target. Collectively, these findings support a contribution of miRNAs at 14q32 in ccRCC pathogenesis.

Indexed as

14q32ATXN2ccRCCclaudin-1DNMT1ironLPAmiRNA

Identifiers

PMID37139155
PMCPMC10150008
OpenAlexW4366219497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.